• Welcome, Guest. Please login or register.
    October 27, 2020, 12:35:40 AM

  • Login with username, password and session length

Sajid's dove

Tell everyone they can now find this site by typing this into their browser:

thalpal.com

Click to visit us on Facebook


If you have any problems registering or signing in, please send an email to: andythalpal@yahoo.com
Please do not send questions about thalassemia to this address.


Administrators
Andy
Danielle

Thalassemia Patients and Friends and thalpal © A. Battaglia 2019





55394 Posts in 5926 Topics by 6238 Members
Latest Member: MytiMouse

This is Thalassemia Patients and Friends,
dedicated to its founder,
Lisa Cammilleri.
(1970-2004)
« previous next »
Pages: 1 Go Down Print
Author Topic: CN128: A New Orally Active Hydroxypyridinone Iron Chelator  (Read 663 times)
ironjustice
Junior Member
***
Offline Offline

Posts: 134


« on: August 12, 2020, 09:44:33 PM »

CN128: A New Orally Active Hydroxypyridinone Iron Chelator
Wenteng Chen, Xin Yuan, Zhi Li, Zidong Lu, Sisi Kong, Huidi Jiang, Houbing Du, Xiuhong Pan, Manasi Nandi, Xiaole Kong, Kathryn Brown, Zudong Liu, Guolin Zhang, Robert C. Hider*, and Yongping Yu*
Cite this: J. Med. Chem. 2020, 63, 8, 4215–4226
Publication Date:March 25, 2020
https://doi.org/10.1021/acs.jmedchem.0c00137
Copyright © 2020 American Chemical Society
https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00137

"now in clinical trials for the treatment of β-thalassemia after regular blood transfusion."
Logged
Pages: 1 Go Up Print 
« previous next »
Jump to:  

Powered by MySQL Powered by PHP Powered by SMF 1.1.21 | SMF © 2015, Simple Machines Valid XHTML 1.0! Valid CSS!